BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35779626)

  • 1. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive overview of how to fade into succinate dehydrogenase dysregulation in cancer cells by naringenin-loaded chitosan nanoparticles.
    Ragab EM; Khamis AA; Gamal DME; Mohamed TM
    Genes Nutr; 2024 May; 19(1):10. PubMed ID: 38802732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells.
    Huang YC; Yang CH; Chiou YL
    Phytomedicine; 2011 Nov; 18(14):1244-9. PubMed ID: 21802267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive and anti-inflammatory effect of Naringenin in different nociceptive and inflammatory mice models.
    Xue N; Wu X; Wu L; Li L; Wang F
    Life Sci; 2019 Jan; 217():148-154. PubMed ID: 30414428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells.
    Yang J; Li Q; Zhou XD; Kolosov VP; Perelman JM
    Mol Cell Biochem; 2011 May; 351(1-2):29-40. PubMed ID: 21229383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Mitochondrial BK
    Kicinska A; Kampa RP; Daniluk J; Sek A; Jarmuszkiewicz W; Szewczyk A; Bednarczyk P
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective.
    Zobeiri M; Belwal T; Parvizi F; Naseri R; Farzaei MH; Nabavi SF; Sureda A; Nabavi SM
    Curr Pharm Biotechnol; 2018; 19(3):196-205. PubMed ID: 29766801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on the protective effects of naringenin against natural and chemical toxic agents.
    Naraki K; Rezaee R; Karimi G
    Phytother Res; 2021 Aug; 35(8):4075-4091. PubMed ID: 33724584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
    Xu J; Guo Z; Yuan S; Li H
    Mol Cell Biochem; 2022 May; 477(5):1541-1553. PubMed ID: 35184257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review on Pharmacological and Analytical Aspects of Naringenin.
    Patel K; Singh GK; Patel DK
    Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest.
    Ahamad MS; Siddiqui S; Jafri A; Ahmad S; Afzal M; Arshad M
    PLoS One; 2014; 9(10):e110003. PubMed ID: 25330158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
    Hernández-Aquino E; Muriel P
    World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.
    Arafah A; Rehman MU; Mir TM; Wali AF; Ali R; Qamar W; Khan R; Ahmad A; Aga SS; Alqahtani S; Almatroudi NM
    Plants (Basel); 2020 Dec; 9(12):. PubMed ID: 33339267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Potential of Naringenin: A Review of Clinical Trials.
    Salehi B; Fokou PVT; Sharifi-Rad M; Zucca P; Pezzani R; Martins N; Sharifi-Rad J
    Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30634637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
    Arul D; Subramanian P
    Pathol Oncol Res; 2013 Oct; 19(4):763-70. PubMed ID: 23661153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin Nano-Delivery Systems and Their Therapeutic Applications.
    Bhia M; Motallebi M; Abadi B; Zarepour A; Pereira-Silva M; Saremnejad F; Santos AC; Zarrabi A; Melero A; Jafari SM; Shakibaei M
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.